Skip to main content
Premium Trial:

Request an Annual Quote

Caprion Identifies Protein Biomarkers for Predicting Patient Response to New Hepatitis C Drug

Premium

Caprion Proteomics announced this week that it has identified a panel of protein biomarkers that could be useful in predicting patient response to a new treatment for hepatitis C.

The company said that the biomarkers were correlated with sustained viral response or viral cure in response to a combined treatment of pegylated-interferon, ribavirin, and telaprevir, a drug candidate for hepatitis C.

The study was part of a collaboration between Caprion and Vertex Pharmaceuticals, the maker of telaprevir. Caprion used its s mass spectrometry-based proteomics platform CellCarta to discover the markers by comparing the expression levels of thousands of proteins in blood samples from hepatitis C patients.

The study also suggested potential differences within the segments of the hepatitis C patient population that could be used for stratification and tailoring individual therapies, Caprion said.

Research on the biomarkers in larger patient populations is currently underway, and the company plans to perform further validation assays on the panel using its multiple-reaction monitoring mass spec platform.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.